Earnings Call · Q3 FY2025·2025-11-12

Q3 25EPS +4.00%·Rev n/aQ2 25EPS +20.00%·Rev n/aQ1 25EPS -51.28%·Rev n/aQ4 24EPS +71.26%·Rev n/a⚠ consensus missing

BioCardia, Inc. BCDA

Miranda Peto — Investor Relations or Communications

Peter Altman — President and Chief Executive Officer

David McClung — Chief Financial Officer

−2.3%1d on move date−2.3% vs SPY3d−7.5%5d−3.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCDA calls or request research access.

More BCDA calls Browse calls Request research access